- Home
- DCOM vs ATAI Comparison
DCOM vs ATAI Comparison
Compare DCOM & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DCOM | ATAI |
|---|---|---|
| Founded | 1864 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | DCOM | ATAI |
|---|---|---|
| Price | $32.56 | $3.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $36.40 | $15.29 |
| AVG Volume (30 Days) | 210.7K | ★ 3.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.04% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $308,000.00 |
| Revenue This Year | $21.40 | $955.84 |
| Revenue Next Year | $12.62 | N/A |
| P/E Ratio | $14.81 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $23.25 | $1.15 |
| 52 Week High | $36.86 | $6.73 |
Technical Indicators
Market Signals| Indicator | DCOM | ATAI |
|---|---|---|
| Relative Strength Index (RSI) | 43.51 | 46.12 |
| Support Level | $25.67 | $3.42 |
| Resistance Level | $34.86 | $4.28 |
| Average True Range (ATR) | 1.44 | 0.30 |
| MACD | -0.40 | -0.02 |
| Stochastic Oscillator | 24.64 | 25.13 |
Price Performance
Historical ComparisonAbout DCOM Dime Community Bancshares Inc.
Dime Community Bancshares Inc operates as a holding company. It gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.